Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
University of Michigan Rogel Cancer Center
Exelixis
Merck Sharp & Dohme LLC
RayzeBio, Inc.
Rezolute
UMC Utrecht
Universidad Nacional Autonoma de Mexico
Aadi Bioscience, Inc.
AC Camargo Cancer Center